<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04996849</url>
  </required_header>
  <id_info>
    <org_study_id>PCR04-0148</org_study_id>
    <secondary_id>NCI-2021-07693</secondary_id>
    <secondary_id>PCR04-0148</secondary_id>
    <nct_id>NCT04996849</nct_id>
  </id_info>
  <brief_title>Contemporary Characteristics of Penile Cancer</brief_title>
  <official_title>Contemporary Characteristics of Penile Carcinoma: at M.D. Anderson Cancer Center, and Harris Health System and Katy, Sugar Land, the Woodlands and Bay Area Regional Care Centers</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>M.D. Anderson Cancer Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute (NCI)</agency>
      <agency_class>NIH</agency_class>
    </collaborator>
  </sponsors>
  <source>M.D. Anderson Cancer Center</source>
  <brief_summary>
    <textblock>
      This study develops a prospective database of patients who are evaluated and treated for&#xD;
      penile cancer. This will facilitate analyzing trends in cancer incidence, risk factors,&#xD;
      treatment, complications, and tumor progression. It will also prospectively validate the&#xD;
      importance of pathological prognostic factors previously reported and outcome related to&#xD;
      contemporary treatment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      PRIMARY OBJECTIVE:&#xD;
&#xD;
      I. To prospectively collect data on the presenting features, management and outcome of penile&#xD;
      carcinoma at M.D. Anderson Cancer Center, and Harris Health System and Katy, Sugar Land, The&#xD;
      Woodlands and Bay Area Regional Care Centers.&#xD;
&#xD;
      OUTLINE:&#xD;
&#xD;
      Patients undergo data collection every 6 months for up to 15 years.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 22, 2004</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Prospectively collect data on the presenting features, management and outcome of penile carcinoma</measure>
    <time_frame>Up to 15 years</time_frame>
    <description>Descriptive statistics will be utilized where applicable to address questions relevant to the study aims.</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Penile Carcinoma</condition>
  <condition>Squamous Cell Carcinoma of the Penis</condition>
  <arm_group>
    <arm_group_label>Observational (data collection)</arm_group_label>
    <description>Patients undergo data collection every 6 months for up to 15 years.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Data Capture</intervention_name>
    <description>Data collected</description>
    <arm_group_label>Observational (data collection)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Questionnaire Administration</intervention_name>
    <description>Ancillary studies</description>
    <arm_group_label>Observational (data collection)</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients diagnosed with a primary penile malignancy&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  All diagnosed patients with a primary penile malignancy, including those with squamous&#xD;
             carcinoma&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  No patient meeting the above criteria will be excluded&#xD;
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Curtis A Pettaway</last_name>
    <role>Principal Investigator</role>
    <affiliation>M.D. Anderson Cancer Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>M D Anderson Cancer Center</name>
      <address>
        <city>Houston</city>
        <state>Texas</state>
        <zip>77030</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Curtis A. Pettaway</last_name>
      <email>cpettawa@mdanderson.org</email>
    </contact>
    <investigator>
      <last_name>Curtis A. Pettaway</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.mdanderson.org</url>
    <description>MD Anderson Cancer Center Website</description>
  </link>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 30, 2021</study_first_submitted>
  <study_first_submitted_qc>July 30, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 9, 2021</study_first_posted>
  <last_update_submitted>July 30, 2021</last_update_submitted>
  <last_update_submitted_qc>July 30, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 9, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carcinoma</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

